GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis India Ltd (BOM:500672) » Definitions » PS Ratio

Novartis India (BOM:500672) PS Ratio : 8.15 (As of May. 24, 2024)


View and export this data going back to 1991. Start your Free Trial

What is Novartis India PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Novartis India's share price is ₹1105.80. Novartis India's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₹135.70. Hence, Novartis India's PS Ratio for today is 8.15.

Warning Sign:

Novartis India Ltd stock PS Ratio (=8.03) is close to 10-year high of 8.12

The historical rank and industry rank for Novartis India's PS Ratio or its related term are showing as below:

BOM:500672' s PS Ratio Range Over the Past 10 Years
Min: 1.31   Med: 3.59   Max: 8.15
Current: 8.15

During the past 13 years, Novartis India's highest PS Ratio was 8.15. The lowest was 1.31. And the median was 3.59.

BOM:500672's PS Ratio is ranked worse than
86.9% of 1000 companies
in the Drug Manufacturers industry
Industry Median: 2.18 vs BOM:500672: 8.15

Novartis India's Revenue per Sharefor the three months ended in Mar. 2024 was ₹32.85. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₹135.70.

Warning Sign:

Novartis India Ltd revenue per share has been in decline for the last 5 years.

During the past 12 months, the average Revenue per Share Growth Rate of Novartis India was -11.50% per year. During the past 3 years, the average Revenue per Share Growth Rate was -2.90% per year. During the past 5 years, the average Revenue per Share Growth Rate was -4.70% per year. During the past 10 years, the average Revenue per Share Growth Rate was -6.60% per year.

During the past 13 years, Novartis India's highest 3-Year average Revenue per Share Growth Rate was 13.10% per year. The lowest was -11.80% per year. And the median was -3.90% per year.

Back to Basics: PS Ratio


Novartis India PS Ratio Historical Data

The historical data trend for Novartis India's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novartis India PS Ratio Chart

Novartis India Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.01 3.73 3.76 3.69 7.58

Novartis India Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.69 5.74 5.45 5.79 7.58

Competitive Comparison of Novartis India's PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Novartis India's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novartis India's PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Novartis India's PS Ratio distribution charts can be found below:

* The bar in red indicates where Novartis India's PS Ratio falls into.



Novartis India PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Novartis India's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=1105.80/135.701
=8.15

Novartis India's Share Price of today is ₹1105.80.
Novartis India's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹135.70.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Novartis India  (BOM:500672) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Novartis India PS Ratio Related Terms

Thank you for viewing the detailed overview of Novartis India's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Novartis India (BOM:500672) Business Description

Traded in Other Exchanges
N/A
Address
Inspire BKC, Part of 601 & 701, Bandra Kurla Complex, Bandra (East), Mumbai, MH, IND, 400 051
Novartis India Ltd is an Indian-based pharmaceutical company. The company is engaged in the trading of Drugs and Pharmaceuticals. It derives revenue from operations in India. The company single business segment namely Pharmaceuticals, Its Pharmaceutical business focuses on Bone and Pain, Calcium portfolio, Gynecology, and Neurosciences.

Novartis India (BOM:500672) Headlines

No Headlines